Patent ID: 9409954
Filing Date: 2016-08-09
CPC Classification: A61K,A61P,C07K,C12N

Claim Text:
1. A recombinant nonpathogenic Marek's Disease Virus (rMDV np ) comprising a first nucleic acid inserted in a first nonessential site in the rMDV np genome and a second nucleic acid inserted in a second nonessential site in the rMDV np genome; wherein the first nucleic acid comprises both a nucleotide sequence that encodes an Infectious Laryngotracheitis Virus glycoprotein D (ILTVgD) and a nucleotide sequence that encodes an Infectious Laryngotracheitis Virus glycoprotein I (ILTVgl); wherein the second nucleic acid comprises a nucleotide sequence that encodes a Newcastle Disease Virus fusion protein (NDV F); wherein the first nonessential site and the second nonessential site are either both the UL54.5 site or only the first nonessential site is the US2 site; and wherein the rMDV